Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.51 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.51 |
| ▸ | AGT | P01019 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.35 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9024777 | 1.00 | AGTR1 (0.51) | AGTR1AGTR2AGTPTGS2AKT1 | |
| SCHEMBL27586872 | 0.88 | AGTR1 (0.44) | AGTR1AGTR2AGTPTGS2P2RX7 | |
| SCHEMBL29931122 | 0.88 | AGTR1 (0.44) | AGTR1AGTR2AGTPTGS2P2RX7 | |
| SCHEMBL13146764 | 0.88 | AGTR1 (0.55) | AGTR1AGTR2AGTKCNN4TSHR | |
| SCHEMBL8539585 | 0.88 | AGTR1 (0.52) | AGTR1AGTR2AGTAKT1P2RX7 | |
| SCHEMBL29404889 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2AGTTSHRP2RX7 | |
| SCHEMBL8246839 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2AGTP2RX7HDAC6 | |
| SCHEMBL4246354 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2AGTAKT1P2RX7 | |
| SCHEMBL796 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2AGTTSHRP2RX7 | |
| SCHEMBL9307853 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2AGTP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115792063-B | Method for detecting related substances of olmesartan medoxomil hydrochlorothiazide tablets | 珠海润都制药股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-115792063-B | Method for detecting related substances of olmesartan medoxomil hydrochlorothiazide tablets | 珠海润都制药股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-118546100-B | Method for synthesizing tetrazole by recovering triphenylmethyl ether in alisartan ester waste residues | 山东信立泰药业有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118546100-A | Method for synthesizing tetrazole by recovering triphenylmethyl ether in alisartan ester waste residues | 山东信立泰药业有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-116813552-A | Recovery and purification process of olmesartan intermediate impurities | 江苏阿尔法药业股份有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-115792063-A | Method for detecting related substances of olmesartan medoxomil hydrochlorothiazide tablets | 珠海润都制药股份有限公司 | 2023-03-14 | — | — | CN | disclosed |